Arcutis Biotherapeutics has returned an impressive +200% YTD, following the successful product launch of Zoryve. See why I rate ARQT stock as a Strong Buy.
From stretchy knit uppers that offer maximum breathability to cushion-heavy outsoles, these Asics sneakers promise the best workout or rest day of your life.